Form 4 for KYMR Kymera Therapeutics, Inc.
Accepted 2025-06-03 00:00:00 ET · period of report 2025-06-03 · accession 0000950170-25-081200 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-06-03 | 2025-06-03 | KYMR | Ridloff Elena | Dir | S - Sale+OE | $46.10 | -12.0K | 4,800 | -71% | -$553.2K |
| DT | 2025-06-03 | 2025-06-03 | KYMR | Ridloff Elena | Dir | M - OptEx | $27.67 | +12.0K | 12.0K | New | +$332.0K |
| DT | 2025-06-03 | 2025-06-03 | KYMR | Ridloff Elena | Dir | M - OptEx | $0.00 | -12.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-03 | S | D | 4,800 | $47.00 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2025-06-03 | M | A | 12,000 | $27.67 | 12,000 | D | — | — | |
| 3 | Common | Common Stock | 2025-06-03 | S | D | 7,200 | $45.50 | 4,800 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2025-06-03 | M | D | 12,000 | $0.00 | 0 | D | $27.67 · — to 2033-06-15 | 12,000 Common Stock | (F2) The shares underlying this stock option are fully vested and exercisable. |